AzTrials
AzTrials

Mild DementiaACTIVENCT07321587

Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise

A study testing ACTIVE Intervention in people with Mild Dementia, run by NYU Langone Health at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a multi-methods two-arm, crossover, analyst-blinded randomized controlled trial with embedded qualitative interviews, enrolling 50 dyads (older adult-care partner). Participants will receive the ACTIVE intervention, which includes a Fitbit smartwatch, motivational text messages to engage in walking exercise… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Mild Dementia
What is being tested?
ACTIVE Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
26 Jan 2026to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Older Adults:
  • Age ≥65 years.
  • With or without mild dementia.
  • Willing to consent to participate in the study or have an LAR that is willing to consent for their participation in the study
  • Willing to wear a Fitbit smartwatch, receive text messages, watch intervention-related videos, participate in physical therapy, and walking exercise.
  • No contraindications to engaging in physical activity.
Show all 13Show fewer
  • Care Partners:
  • Age ≥18 years.
  • Met criteria for survey participation.
  • Person being cared for is recruited in the study.
  • Willing to consent to participation
  • Willing to wear a Fitbit smartwatch, receive text messages, watch intervention-related videos, participate in physical therapy, and walking exercise.
  • No contraindications to engaging in physical activity.

Who cannot join

  • Older Adults:
  • Severe cardiac, neurologic, or musculoskeletal condition (including but not limited to recent or untreated fracture in any part of the body)
  • limiting participation in daily walking or Fitbit smartwatch use.
  • Moderate to severe dementia (using the clinical dementia rating scale of 2 or higher
  • Inability to operate or manage a Fitbit smartwatch device (even with care partner support).
  • No phone or phone not capable of receiving text messages or watching videos.
Show all 15Show fewer
  • No internet for watching videos
  • Care Partners:
  • Severe cardiac, neurologic, or musculoskeletal condition limiting participation in daily walking or Fitbit smartwatch use.
  • Pregnant care partners
  • Any level of dementia or cognitive impairment among care partners
  • Inability to operate or manage a Fitbit smartwatch device.
  • Inability to co-participate in intervention tasks with older adult
  • No phone or phone not capable of receiving text messages or watching videos.
  • No internet for watching videos

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Oluwaseun Adeyemi, MD, PhD contact

980-939-9764

Oluwaseun.Adeyemi@nyulangone.org

United States1 site, 1 recruiting
  • NYU Langone Health

    New York, New York, 10016

    Recruiting

Other trials in United States

About this study

Official title: Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise (ACTIVE) Intervention Among Older Adults With and Without Mild Dementia

This is a multi-methods two-arm, crossover, analyst-blinded randomized controlled trial with embedded qualitative interviews, enrolling 50 dyads (older adult-care partner). Participants will receive the ACTIVE intervention, which includes a Fitbit smartwatch, motivational text messages to engage in walking exercise, instructional educational videos, and virtual physical therapy sessions. Intervention components will be delivered over 3 weeks, with continuous monitoring of physical activity via Fitbit data, read receipts of the motivational text messages, and log of engagement in the virtual physical therapy and educational videos.

Conditions
Mild Dementia
Being tested
ACTIVE Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACTIVE InterventionBehavioural

    The ACTIVE Intervention comprises the following components:

    • Fitbit Smartwatch-Based Activity Tracking
    • Care Partner Co-Participation
    • Motivational Text Messaging
    • Instructional Education Videos
    • Virtual Physical Therapy
    • Exercise (Walking Exercise)
Study groups in NCT07321587
Study groupRoleWhat they receive
Intervention, then ControlExperimentalWeek 1 (Pre-Intervention): Participants will wear the Fitbit smartwatch during waking hours. Data collected during this week will serve as baseline and for troubleshooting technical issues. Weeks 2-4 (Intervention): Participants will receive the ACTIVE intervention (Activity tracking, Care partner co-participation, Text reminders, Instructional education, Virtual physical therapy and Exercise). Week 5 (Crossover/Washout): Participants will switch arms (intervention to control). Weeks 6-8 (Control): Participants will continue in the control arm (Fitbit use only).
Receives: Behavioral: ACTIVE Intervention
Control, then InterventionExperimentalWeek 1 (Pre-Control): Participants will wear the Fitbit smartwatch during waking hours. Data collected during this week will serve as baseline and for troubleshooting technical issues. Weeks 2-4 (Control): Participants will continue in the control arm (Fitbit use only). Week 5 (Crossover/Washout): Participants will switch arms (control to intervention). Weeks 6-8 (Intervention): Participants will the ACTIVE intervention (Activity tracking, Care partner co-participation, Text reminders, Instructional education, Virtual physical therapy and Exercise).
Receives: Behavioral: ACTIVE Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adoption

    Measured as the proportion of participants who initiate use of each intervention component:

    • Smartwatch: device activated and worn for ≥3 days during week 1.
    • Text reminders: ≥1 responses to text message opened/read in week 1.
    • Virtual PT videos: at least one session accessed in week 1, which will be tracked online through participant specific username.
    • Instructional education videos: at least one video accessed in week 1,which will be tracked online through participant specific username.

    Measured: Up to Week 7 (End of Week 1 of Intervention Period)

  2. Feasibility: Smartwatch

    Measured as sustained engagement with each component during the 3-week intervention:

    • Smartwatch: proportion of days with ≥8 hours of wear time (captured on Fitabase).
    • Text reminders: proportion of responses to text messages (captured on Fitabase) opened or acknowledged.
    • Virtual PT videos: proportion of assigned sessions completed (captured on myACTIVEsteps.com via username); feasibility target.
    • Instructional education videos: proportion of assigned videos completed (captured on myACTIVEsteps.com via username.

    Measured: Up to Week 8

  3. Feasibility: Motivational Texts

    Measured as sustained engagement with each component during the 3-week intervention:

    • Text reminders: proportion of responses to text messages (captured on Fitabase) opened or acknowledged.
    • Virtual PT videos: proportion of assigned sessions completed (captured on myACTIVEsteps.com via username); feasibility target.
    • Instructional education videos: proportion of assigned videos completed (captured on myACTIVEsteps.com via username.

    Measured: Up to Week 8

  4. Feasibility: Virtual Physical Therapy

    Measured as sustained engagement with each component during the 3-week intervention:

    • Virtual PT videos: proportion of assigned sessions completed (captured on myACTIVEsteps.com via username); feasibility target.
    • Instructional education videos: proportion of assigned videos completed (captured on myACTIVEsteps.com via username.

    Measured: Up to Week 8

  5. Feasibility: Instructional Education Videos

    Measured as sustained engagement with each component during the 3-week intervention:

    • Instructional education videos: proportion of assigned videos completed (captured on myACTIVEsteps.com via username.

    Measured: Up to Week 8

  6. Acceptability: System Usability Scale (SUS)

    The SUS is a 10-item survey assessing the usability of a system. Each item is rated on a Likert scale from 1-5; the raw score is the sum of responses, which is transformed to a standardized score ranging from 0-100; higher scores indicate greater usability.

    Measured: Up to Week 10

  7. Acceptability: Perceived Usefulness (PU): Smartwatch

    The PU survey is a 5-item assessment of perceived usefulness of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived usefulness.

    Measured: Up to Week 10

  8. Acceptability: Perceived Usefulness (PU): Motivational Texts

    The PU survey is a 5-item assessment of perceived usefulness of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived usefulness.

    Measured: Up to Week 10

  9. Acceptability: Perceived Usefulness (PU): Instructional Education Videos

    The PU survey is a 5-item assessment of perceived usefulness of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived usefulness.

    Measured: Up to Week 10

  10. Acceptability: Perceived Usefulness (PU): Virtual Physical Therapy

    The PU survey is a 5-item assessment of perceived usefulness of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived usefulness.

    Measured: Up to Week 10

  11. Acceptability: Perceived Ease-of-Use (PEU): Smartwatch

    The PEU survey is a 5-item assessment of perceived ease-of-use of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived ease-of-use.

    Measured: Up to Week 10

  12. Acceptability: Perceived Ease-of-Use (PEU): Motivational Texts

    The PEU survey is a 5-item assessment of perceived ease-of-use of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived ease-of-use.

    Measured: Up to Week 10

  13. Acceptability: Perceived Ease-of-Use (PEU): Instructional Education Videos

    The PEU survey is a 5-item assessment of perceived ease-of-use of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived ease-of-use.

    Measured: Up to Week 10

  14. Acceptability: Perceived Ease-of-Use (PEU): Virtual Physical Therapy

    The PEU survey is a 5-item assessment of perceived ease-of-use of technology. Each item is rated on a Likert scale from 1-7. The score is calculated as the average of responses and ranges from 1-7; higher scores indicate greater perceived ease-of-use.

    Measured: Up to Week 10

  15. Intervention Delivery Fidelity

    Proportion of intervention components successfully delivered by study staff.

    Measured: Up to Week 8.

  16. Participant Fidelity

    Proportion of assigned intervention activities completed, verified via Fitbit logs, video analytics, and message tracking.

    Measured: Up to Week 8.

  17. Change in Falls Efficacy Scale-International (FES-I) Score

    FESI-I is a 16-item self-report questionnaire assessing older adults' fear about falling during daily activities. Each item is rated on a Likert scale from 1-4 (not at all to very concerned). The total score is the sum of responses and ranges from 16-64, where higher scores mean more fear and less confidence.

    Measured: Baseline, Up to Week 10

  18. Change in Activities of Daily Living (ADL) Score

    The ADL ranks adequacy of performance in the six functions of bathing, dressing, toileting, transferring, continence, and feeding. Participants are scored yes/no for independence in each of the six functions. A score of 6 indicates full function, 4 indicates moderate impairment, and 2 or less indicates severe functional impairment.

    Measured: Baseline, Up to Week 10

  19. Change in Instrumental Activities of Daily Living (IADL) Score

    IADL is an 8-item assessment of independence in completing complex tasks. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias.

    Measured: Baseline, Up to Week 10

  20. Change in Knowledge, Attitude, and Practice (KAP) of Physical Exercise: Knowledge Score

    The Knowledge subsection of the KAP survey comprises 20 items assessing knowledge of physical exercise. Each item is rated on a Likert scale from 1-5. The total score is the sum of responses and ranges from 20-100; higher scores indicate greater knowledge.

    Measured: Baseline, Up to Week 10

  21. Change in Knowledge, Attitude, and Practice (KAP) of Physical Exercise: Attitude Score

    The Attitude subsection of the KAP survey comprises 10 items assessing attitude toward physical exercise. Each item is rated on a Likert scale from 1-5. The total score is the sum of responses and ranges from 10-50; higher scores indicate more positive attitude toward physical exercise.

    Measured: Baseline, Up to Week 10

  22. Change in Knowledge, Attitude, and Practice (KAP) of Physical Exercise: Attitude Score

    The Practice subsection of the KAP survey comprises 10 items assessing practice of physical exercise. Each item is rated on a Likert scale from 1-5. The total score is the sum of responses and ranges from 10-50; higher scores indicate greater practice of physical exercise.

    Measured: Baseline, Up to Week 10

  23. Change in Short Form - 12 Quality of Life Survey (SF-12)

    The SF-12 is a 12-item assessment of quality of life. Each item is rated on a Likert scale from 1-5. The raw score is the sum of responses; the raw score is converted to a standardized score ranging from 0-100 with a mean of 50 and standard deviation of 10. Higher scores indicate greater quality of life.

    Measured: Baseline, Up to Week 10

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2026
  2. Study start26 Jan 2026
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07321587
Sponsor's protocol ID
25-01158
Acronym
ACTIVE
Status last verified
Jan 2026
First submitted
23 Dec 2025
Last updated
28 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: Oluwaseun.Adeyemi@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Questions about this trial

What is this clinical trial studying?

A study testing ACTIVE Intervention in people with Mild Dementia, run by NYU Langone Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Oluwaseun Adeyemi, MD, PhD (980-939-9764, Oluwaseun.Adeyemi@nyulangone.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adoption (time frame: Up to Week 7 (End of Week 1 of Intervention Period)). The study lists 23 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in